Alternatives to Balanced Hormone Health

From $133/mo semaglutide, $209/mo tirzepatide, all 50 states, and an explicit pregnancy/breastfeeding exclusion most competitors don't bother disclosing — the price just isn't flat, it's tiered by how many months you prepay.

A flat $239/mo semaglutide, $399/mo tirzepatide, no-video intake with free overnight shipping — but it's only live in 23 states, and most big population centers aren't on the list.

A high-volume general telehealth platform, not a GLP-1 specialist — $99 flat for a one-time doctor consultation with no membership, but the medication cost is billed separately and never itemized, so the real monthly total is unknown until you fill the prescription.

The insurance-and-brand heavyweight: a WeightWatchers-run membership that routes you toward FDA-approved product and insurance coverage, with a video visit required in some states — the membership fee and the medication bill are two separate charges.

FDA warning letter #728279 (Jun. 2026), which names tryeden.com. Read live on 2026-08-26, the GLP-1 page prices compounded semaglutide at $99 a month and compounded tirzepatide at $199 — and the asterisk under both figures is the part that changes the math. It reads: price includes medication only, an active Eden Membership is required at $39 for the first month and $99 a month thereafter, and medication is not available without a membership. So this is two line items, not one, and the second one is not next to the number on the page. What Eden does give you is range: brand Zepbound, Ozempic and Mounjaro at $1,399 a month and Wegovy at $1,695, each on its own product page marked In Stock, alongside the compounded lane. It says it serves GLP-1 programs in all fifty states, and its "same price at every dose" policy means titrating up does not raise the medication line. Cancellation is self-serve in the portal, though the Terms want 48 hours' notice before a renewal and make charges non-refundable once an order is fulfilled.

A one-product shop — compounded tirzepatide microdosing only, $89 the first month then $199/mo all-in, no live video visit described anywhere in the flow, and unusually candid on-site that the trial evidence for microdosing specifically is thin — but there's no semaglutide option at all, and no individual physician, pharmacy, or state list named anywhere on the site checked.

You cannot budget this one in advance, and that is a deliberate feature rather than an oversight. RxPepsDirect charges a flat $39 per visit for the provider review and the script; the medication is billed straight to you by Optimal Balance Pharmacy at wholesale with no markup — "typical pharmacy bill: $25 to $200" — plus $15 for FedEx overnight. No subscription, no tiers, no membership, and one visit covers up to three peptides. The trade is transparency of margin against certainty of total.

AskRx solves the pricing question most of this page leaves open, and creates a different one. Its care fee is itemized in its own footnote — $90/month physician visit, $10/month fulfilment, $100 total — and the medication is billed separately through its own pharmacy, at cost, with both halves shown at checkout. If you have ever wondered how much of a blended monthly price is the drug and how much is margin, this is the provider that answers it. It is FDA-approved only ('No compounded meds'), so the options are the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the oral tirzepatide. All 50 states, board-certified physicians with obesity-medicine training, unlimited messaging, monthly titration, cancel anytime. Two logistics notes that matter on a workday. First, $100 is a floor: no medication price is published, so your real monthly total is unknown until checkout and depends on coverage. Second — and read this one if scheduling is your constraint — 'video visits available in select states' means the async route is not universal here, so confirm your own state before assuming you can do this without a call.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.